PEAK PHARMACEUTICALS, INC. Adjustments to Additional Paid in Capital, Income Tax Deficiency from Share-based Compensation
PEAK PHARMACEUTICALS, INC. (RMHI) reported Adjustments to Additional Paid in Capital, Income Tax Deficiency from Share-based Compensation of $214.11 thousand for the 9-month period ending 2018-06-30, per its 10-Q filed 2018-08-13.
Discontinued › Notes › Compensation Related Costs
us-gaap:AdjustmentsToAdditionalPaidInCapitalIncomeTaxDeficiencyFromShareBasedCompensation · last filed 2018-08-13
- PEAK PHARMACEUTICALS, INC. adjustments to additional paid in capital, income tax deficiency from share-based compensation for the quarter ending 2018-06-30 was $4.41K.
- PEAK PHARMACEUTICALS, INC. adjustments to additional paid in capital, income tax deficiency from share-based compensation for the quarter ending 2018-03-31 was $9.39K.
- PEAK PHARMACEUTICALS, INC. adjustments to additional paid in capital, income tax deficiency from share-based compensation for the quarter ending 2017-12-31 was $200.31K.
| Period end | Adjustments to Additional Paid in Capital, Income Tax Deficiency from Share-based Compensation 3 month | Adjustments to Additional Paid in Capital, Income Tax Deficiency from Share-based Compensation 6 month | Adjustments to Additional Paid in Capital, Income Tax Deficiency from Share-based Compensation 9 month |
|---|---|---|---|
| 2018-06-30 | $4.41K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-08-13 | $13.80K derived: sum of 2 quarters · filed 2018-08-13 | $214.11K 10-Q · filed 2018-08-13 |
| 2018-03-31 | $9.39K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-05-14 | $209.70K 10-Q · filed 2018-05-14 | |
| 2017-12-31 | $200.31K 10-Q · filed 2018-02-15 |